Trial Profile
A Randomized, Double-Blind, Vehicle-Controlled Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2016
Price :
$35
*
At a glance
- Drugs Tazarotene (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 23 Dec 2016 Status changed from recruiting to completed.
- 09 Mar 2016 New trial record